Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study. The specific aims of the measures and decision aid development phase of this project are as follows: Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers. Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.



Eligible Ages
Between 55 Years and 80 Years
Eligible Genders
Accepts Healthy Volunteers

Inclusion Criteria

  1. Men and women 55 to 80 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years.

Exclusion Criteria

  1. History of lung cancer.

Study Design

Study Type
Observational Model
Time Perspective

Arm Groups

ArmDescriptionAssigned Intervention
Lung Cancer Screening Decision Aids Participants are asked to look over education materials about lung cancer screening, and interviewed. Some participants will look at a video patient decision aid, with an interview and questionnaire completion. Some participants complete lung cancer screening knowledge questionnaire at first visit, and then again in one month.
  • Behavioral: Interviews
    Interviews performed by study staff encompassing lung cancer screening and patient decision aids.
  • Behavioral: Questionnaires
    Questionnaires completed after viewing patient decision aid video. Questionnaires also completed regarding lung cancer screening knowledge at first visit, then again in one month.
    Other names:
    • Surveys

Recruiting Locations

The University of Texas Medical Branch at Galveston
Galveston, Texas 77555

More Details

M.D. Anderson Cancer Center

Study Contact

Robert Volk, PHD

Detailed Description

Cognitive and Pilot Testing: If you agree to take part in this study, you will take part in an interview with a member of the research staff. The interviewer will take notes of your responses. First, you will be asked some questions about you, like your age, sex, race, and education level. Then you will be asked to look at some educational materials about lung cancer screening. These could be written information, animations, graphics, videos, or questionnaires. You may be asked questions about: - Lung cancer and lung cancer screening - The length of the materials - The balance of the information found in the materials The study interview will take place in person at MD Anderson and will take between 1 and 1 ½ hours. Your participation on this study will be over once the interview is complete. This is an investigational study. Up to 50 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events. Measures Reliability Study: If you agree to take part in this study, you will complete a questionnaire 2 times. The questionnaire will ask about: - Lung cancer - Lung cancer screening - Making decisions about screening - Your age, race, gender, and level of education You will complete the first questionnaire in person. It will take about 20 minutes to fill out. Then, about 1 month later, you will be asked to fill out the questionnaire again. The second time you can come in person, or fill out the questionnaire by mail or telephone. Your participation will be over when the second questionnaire is complete. This is an investigational study. Up to 150 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events.


Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.